Total planned funding: $272,754,022
Allocations
Countries/Regions
Eswatini | $272,754,022 |
Organizational Types
Private Contractor | $71,576,449 |
University | $52,775,746 |
NGO | $52,133,925 |
Unknown | $40,772,999 |
Own Agency | $31,764,874 |
FBO | $10,806,488 |
Host Country Government Agency | $10,022,247 |
Multi-lateral Agency | $1,803,840 |
Other USG Agency | $927,854 |
Implementing Agency | $169,600 |
Program Areas
Care | $75,943,330 |
Treatment | $72,447,362 |
Prevention | $55,463,503 |
Governance and Systems | $26,368,012 |
Testing | $22,096,285 |
Management and Operations | $20,435,530 |
Budget Codes
HTXS: Treatment: Adult Treatment | $62,140,212 |
HBHC: Care: Adult Care and Support | $31,602,014 |
HKID: Care: Orphans and Vulnerable Children | $27,755,662 |
HVCT: Testing: HIV Testing and Counseling | $22,096,285 |
HVMS: Management and Operations | $20,435,530 |
HVOP: Sexual Prevention: Other Sexual Prevention | $18,726,177 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,368,060 |
HVTB: Care: TB/HIV | $11,066,754 |
OHSS: Health Systems Strengthening | $10,935,211 |
HVSI: Strategic Information | $10,545,578 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,611,024 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $7,293,242 |
PDTX: Treatment: Pediatric Treatment | $5,801,133 |
PDCS: Care: Pediatric Care and Support | $5,518,900 |
HLAB: Laboratory Infrastructure | $4,887,223 |
HTXD: Treatment: ARV Drugs | $4,506,017 |
HMBL: Biomedical Prevention: Blood Safety | $1,465,000 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$43,562,370
Countries/Regions
Pact, Inc.:
$34,217,554
Countries/Regions
Not Available:
$22,463,133
Countries/Regions
Chemonics International:
$16,579,695
Countries/Regions